What is the main purpose of the new pharmaceutical manufacturing building?

It aims to strengthen the production system for low-molecular-weight drugs and fully enter contract manufacturing for highly potent and sterile preparations, evolving and expanding TSCS functions.

What exactly is "TSCS"?

It's a Total Supply Chain Service provided by the Alfresa Group, covering everything from pharmaceutical introduction/development, manufacturing, logistics/sales, to post-marketing surveillance and last-mile delivery.

How will the operation of this new building impact the Japanese pharmaceutical market?

It is expected to enhance domestic contract manufacturing capacity, reduce barriers for overseas emerging biopharmaceutical companies entering Japan, and contribute to resolving "drug lag/loss."

AI News NQ Analysis

Operation of New Pharmaceutical Manufacturing Building at Alfresa Pharma Co., Ltd.'s Gunma Plant

NQ Score 50/100

AI Summary (NQ-processed)

Alfresa Pharma Co., Ltd. has commenced operations at its new pharmaceutical manufacturing building at the Gunma Plant, strengthening its contract manufacturing system.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main purpose of the new pharmaceutical manufacturing building?: A: It aims to strengthen the production system for low-molecular-weight drugs and fully enter contract manufacturing for highly potent and sterile preparations, evolving and expanding TSCS functions.
Q: What exactly is "TSCS"?: A: It's a Total Supply Chain Service provided by the Alfresa Group, covering everything from pharmaceutical introduction/development, manufacturing, logistics/sales, to post-marketing surveillance and last-mile delivery.
Q: How will the operation of this new building impact the Japanese pharmaceutical market?: A: It is expected to enhance domestic contract manufacturing capacity, reduce barriers for overseas emerging biopharmaceutical companies entering Japan, and contribute to resolving "drug lag/loss."